Biotech News
TherapeuticsMD Announces Third Quarter 2026 Financial Results
BOCA RATON, Fla. --(BUSINESS WIRE)--Nov. 13, 2026-- TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September 30, 2026.
